Drugs / CARBETAPENTANE
last change Dec 2009 re-read 3 minutes ago

CARBETAPENTANE

Small molecule targets SIGMAR1 via activation

Investigated by
Boehringer Ingelheim

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02183649 Nov → Dec 2009 — Boehringer Ingelheim Completed No outcome recorded

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as CARBETAPENTANE ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Known as CARBETAPENTANE CITRATE ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Known as Loucarbate ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Known as NSC-757833 ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Known as Pentoxiverina ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Known as pentoxyverine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02183649 ↗
Known as pentoxyverine citrate “192 mg Pentoxyverine Citrate (Corresponding to 121.5 mg Pentoxyverine Base)” NCT02183649 ↗
Known as Pentoxyverine hydrogen citrate ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Known as Sedotussin ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Known as Toclase ChEMBL registry synonym — accepted as the source's own label CHEMBL73234 ↗
Action Activate “Sigma opioid receptor agonist” CHEMBL73234 ↗
Modality Small molecule — CHEMBL73234 ↗
Route Oral “After a Single Oral Dose” NCT02183649 ↗
Target SIGMAR1 “Sigma opioid receptor agonist” CHEMBL73234 ↗